estim
reproduct
number
novel
pathogen
essenti
understand
potenti
trajectori
epidem
level
intervent
need
bring
epidem
control
howev
method
estim
basic
reproduct
number
timevari
effect
reproduct
number
rt
assum
fraction
case
detect
report
constant
time
explor
impact
secular
chang
diagnost
test
report
estim
rt
use
simul
data
compar
pattern
data
report
case
test
practic
differ
unit
state
us
state
find
chang
test
practic
delay
report
result
bias
estim
rt
examin
chang
daili
number
test
conduct
percent
patient
test
posit
may
help
identifi
potenti
direct
bia
chang
diagnost
test
report
process
monitor
taken
consider
interpret
estim
reproduct
number
initi
stage
epidem
unit
state
us
character
difficulti
deliv
administ
diagnost
test
first
realtim
quantit
pcr
assay
develop
distribut
us
center
diseas
control
prevent
cdc
suffer
perform
issu
result
initi
confirmatori
test
need
carri
cdc
led
report
delay
capac
issu
earli
epidem
initi
test
administ
individu
histori
travel
certain
countri
known
contact
posit
case
time
test
capac
increas
state
local
health
depart
face
heavi
demand
test
individu
meet
specif
criteria
could
receiv
test
criteria
vari
state
state
time
see
support
inform
si
dataset
concurr
mathemat
model
analyz
data
report
case
order
develop
forecast
futur
incid
evalu
potenti
impact
social
distanc
control
measur
often
behest
policymak
public
health
offici
model
typic
reli
estim
reproduct
number
viru
basic
reproduct
number
defin
expect
number
secondari
infect
produc
infecti
individu
fulli
suscept
popul
use
deriv
expect
fraction
popul
becom
infect
absenc
intervent
level
control
andor
immun
need
elimin
pathogen
circul
timevari
effect
reproduct
number
rt
measur
averag
number
secondari
infect
per
case
timepoint
epidem
use
realtim
monitor
impact
control
measur
control
measur
implement
immun
increas
popul
rt
decreas
valu
estim
growth
rate
number
case
earli
epidem
estim
distribut
gener
time
ie
time
infect
event
success
case
transmiss
chain
wherea
instantan
valu
rt
estim
base
time
seri
case
notif
distribut
gener
time
method
shown
robust
underdetect
underreport
long
probabl
true
case
detect
report
remain
constant
time
use
simul
explor
potenti
magnitud
direct
bias
introduc
chang
diagnost
test
report
practic
similar
occur
earli
stage
epidem
us
comput
preliminari
estim
rt
differ
state
base
publicli
avail
data
covid
track
project
examin
chang
test
practic
trend
cumul
number
test
report
evalu
potenti
estim
bias
base
simul
tabl
fig
likelihood
degre
rt
bias
depend
manner
diagnost
test
practic
report
chang
time
fraction
incid
case
detect
report
constant
time
test
capac
scale
number
true
case
number
confirm
posit
case
provid
unbias
estim
despit
possibl
delay
report
process
fig
fig
instanc
percent
individu
test
posit
expect
stabl
time
estim
rt
also
expect
unbias
first
day
approxim
equal
mean
report
delay
lag
day
behind
detect
decreas
rt
threshold
valu
ie
epidem
reced
fraction
true
case
detect
report
increas
decreas
linearli
time
estim
base
growth
rate
confirm
case
overor
underestim
respect
true
fig
timevari
reproduct
number
rt
also
slightli
overor
underestim
especi
earli
report
delay
gradual
increas
decreas
percent
individu
test
posit
potenti
indic
bia
howev
percent
posit
also
expect
decreas
increas
time
test
capac
expand
less
quickli
number
true
case
respect
fig
instanc
estim
r
r
base
number
confirm
case
unbias
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
abrupt
chang
test
criteria
affect
fraction
true
case
detect
report
also
expect
bia
estim
lead
larg
twofold
temporari
bia
estim
rt
fig
potenti
bia
may
indic
sudden
chang
percent
individu
test
posit
well
temporari
chang
slope
log
cumul
case
similar
chang
percent
posit
may
also
occur
abrupt
chang
test
capac
fig
howev
case
accompani
chang
slope
log
cumul
individu
test
estim
rt
base
fit
number
posit
case
expect
bias
difficult
bia
detect
may
due
chang
report
delay
distribut
fig
case
percent
posit
like
remain
roughli
constant
time
estim
rt
bias
especi
report
delay
increas
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
fraction
true
case
detect
report
increas
day
b
fraction
true
case
detect
report
decreas
day
c
test
capac
increas
individu
per
case
individu
per
case
day
test
ratio
decreas
individu
per
case
individu
per
case
day
e
mean
report
delay
increas
day
day
day
f
mean
report
delay
decreas
day
day
day
bia
due
chang
test
criteria
affect
fraction
true
case
detect
report
fit
model
total
number
individu
test
time
recov
unbias
estim
reproduct
number
fig
thu
percent
posit
test
chang
time
uncertainti
whether
due
chang
test
probabl
test
ratio
fit
model
number
posit
case
total
number
test
may
provid
bound
uncertainti
estim
rt
howev
approach
correct
bia
due
chang
report
delay
distribut
base
number
confirm
case
across
us
march
observ
impact
social
distanc
measur
fig
assum
fix
serial
interv
day
estim
us
confid
interv
ci
account
uncertainti
growth
rate
estim
state
district
columbia
vari
ci
south
dakota
ci
missouri
tabl
estim
base
growth
rate
number
test
perform
similar
entir
us
slightli
larger
averag
individu
state
tabl
nation
percent
individu
test
posit
decreas
earli
march
around
midmarch
earli
declin
percent
posit
like
attribut
increas
test
capac
rather
decreas
fraction
true
case
detect
report
therefor
estim
base
number
confirm
case
unbias
howev
trend
percent
test
posit
vari
state
fig
estim
rt
us
individu
state
gener
high
rt
initi
decreas
time
fig
may
due
low
probabl
detect
case
start
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
epidem
late
februaryearli
march
washington
california
case
us
first
recogn
estim
rt
earli
march
slightli
lower
fig
nation
rt
decreas
less
march
state
rt
alreadi
declin
substanti
stayathom
order
issu
april
last
reliabl
day
could
gener
estim
rt
less
mean
epidem
start
declin
state
hover
around
number
state
eg
california
fig
fig
nation
state
percent
individu
test
posit
gradual
increas
sinc
midmarch
fig
fig
could
occur
either
fraction
individu
infect
detect
report
increas
state
reach
test
capac
individu
like
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
infect
priorit
test
former
analysi
suggest
recent
estim
rt
may
upwardli
bias
moreov
temporari
increas
rt
around
midmarch
state
like
new
york
california
might
due
earli
restrict
test
criteria
howev
abrupt
decreas
percent
test
posit
gener
due
larg
increas
total
number
test
report
therefor
reflect
bia
estim
rt
base
number
confirm
case
first
month
half
epidem
us
test
practic
vari
dramat
time
state
state
si
dataset
april
total
number
test
report
per
capita
vari
test
per
peopl
virginia
test
per
peopl
new
york
due
limit
avail
test
earli
state
recommend
histori
travel
affect
countri
known
contact
confirm
case
test
sinc
diseas
becom
widespread
throughout
us
test
capac
increas
test
guidelin
relax
still
consider
differ
state
state
si
dataset
exampl
april
washington
state
restrict
test
priorit
hospit
individu
essenti
servic
provid
exhibit
symptom
april
new
york
still
recommend
restrict
test
known
posit
contact
travel
histori
well
symptomat
individu
test
neg
infect
test
practic
chang
time
demonstr
chang
may
introduc
bia
estim
rt
affect
infer
much
control
need
control
measur
reduc
transmiss
critic
threshold
necessari
sustain
epidem
estim
mean
us
reason
consist
publish
estim
earli
analys
china
report
rang
assum
mean
serial
interv
day
increas
report
rate
howev
recent
analys
estim
median
ci
analysi
data
europ
us
present
similarli
high
median
valu
rang
assum
serial
interv
day
estim
mean
notabl
lower
base
similar
estim
growth
rate
suggest
differ
attribut
differ
assumpt
serial
interv
estim
rt
wide
report
us
studi
found
r
decreas
start
epidem
follow
travel
restrict
wuhan
variou
european
countri
line
find
monitor
number
test
perform
percent
test
posit
time
help
indic
potenti
bia
estim
reproduct
number
howev
report
test
result
particularli
neg
test
inconsist
mani
state
california
exampl
eightfold
increas
number
neg
test
report
march
anoth
fourfold
increas
april
larg
increas
number
neg
test
accompani
correspond
increas
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
number
confirm
case
thu
estim
rt
base
number
confirm
case
expect
influenc
abrupt
chang
number
report
test
becom
difficult
interpret
interven
gradual
increas
percent
test
posit
difficult
detect
whether
time
onset
infecti
report
test
result
ie
report
delay
chang
time
simul
suggest
chang
could
bia
estim
rt
would
reflect
percent
individu
test
posit
time
individuallevel
data
date
symptom
onset
date
test
date
report
need
resolv
potenti
bia
estim
rt
also
expect
lag
behind
true
chang
transmiss
rate
due
report
delay
nowcast
approach
may
use
resolv
infer
number
infect
occur
day
base
observ
case
hospit
death
known
report
delay
immin
decis
regard
lift
stayathom
order
loosen
social
distanc
requir
measur
may
need
reinstat
depend
good
understand
current
level
transmiss
reliabl
estim
reproduct
number
essenti
quantifi
impact
control
measur
transmiss
make
inform
decis
futur
intervent
eg
howev
chang
test
polici
practic
well
delay
report
process
lead
bia
estim
reproduct
number
demonstr
import
care
document
track
chang
test
report
practic
order
make
correct
infer
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
examin
impact
chang
test
use
simul
data
simul
stochast
seir
susceptibleexposedinfectedrecov
model
explor
potenti
impact
chang
test
practic
estim
rt
model
popul
million
individu
initi
epidem
infecti
individu
minim
chanc
earli
epidem
fadeout
assum
everyon
els
suscept
start
epidem
new
infect
assum
aris
accord
poisson
process
approxim
method
state
transit
rate
describ
tabl
model
paramet
given
tabl
simul
model
day
use
timestep
day
assum
decreas
transmiss
rate
occur
day
consist
impact
social
distanc
intervent
model
run
use
matlab
mathwork
natick
code
avail
http
githubcomvepitzercovidtestingbia
track
number
true
case
day
yd
number
individu
enter
infecti
period
day
assum
true
case
occur
day
probabl
ptest
test
everi
true
case
occur
day
ntest
individu
similar
symptom
test
furthermor
assum
test
report
posit
test
occur
delay
follow
gamma
distribut
paramet
ad
bd
thu
calcul
number
individu
test
td
number
posit
case
cd
day
follow
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
round
valu
td
nearest
integ
sampl
cd
binomi
random
variabl
allow
observ
case
occur
day
even
though
new
case
model
day
examin
impact
report
delay
estim
rt
base
case
assum
probabl
true
case
test
number
individu
test
true
case
assum
mean
report
delay
onset
infecti
test
result
day
model
scenario
fraction
true
case
detect
report
indic
ptest
test
capac
ie
number
individu
test
everi
true
case
ntest
either
increas
decreas
linearli
day
epidem
examin
impact
sudden
chang
probabl
true
case
test
eg
associ
chang
test
criteria
test
capac
eg
associ
new
compani
enter
market
also
explor
scenario
ptest
ntest
increas
decreas
abruptli
day
tabl
final
examin
effect
twofold
increas
decreas
averag
report
delay
estim
growth
rate
epidem
describ
lipsitch
et
al
r
growth
rate
v
serial
interv
also
known
gener
interv
f
proport
serial
interv
spent
latent
period
growth
rate
r
determin
fit
poisson
regress
model
cumul
number
true
case
yd
report
case
cd
day
thu
implicitli
assum
case
occur
first
day
epidem
unlik
recogn
assum
serial
interv
equal
sum
averag
latent
period
averag
infecti
period
proport
serial
interv
spent
latent
period
estim
confid
interv
ci
estim
incorpor
uncertainti
estim
growth
rate
incorpor
uncertainti
f
v
estim
rt
use
wallingateuni
method
likelihoodbas
framework
infer
estim
number
secondari
case
per
case
point
time
base
inform
gener
interv
first
rel
likelihood
case
infect
case
j
estim
base
probabl
distribut
differ
time
symptom
onset
ti
tj
probabl
case
infect
case
k
probabl
distribut
function
gener
interv
assum
case
equival
term
infecti
thu
estim
rt
base
number
true
case
rewritten
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
allow
valu
gener
interv
less
equal
zero
thu
assum
case
infect
case
occur
earlier
day
necessarili
true
account
possibl
report
delay
make
assumpt
estim
rt
base
number
report
case
assum
gener
interv
gamma
distribut
mean
day
coeffici
variat
consist
data
flaxman
et
al
second
reproduct
number
case
j
estim
calcul
weight
sum
pij
case
assum
case
equal
infecti
becom
estim
rt
base
number
true
case
set
estim
rt
day
correct
rightcensor
case
data
divid
estim
rt
cumul
distribut
function
gener
interv
g
x
tmax
explor
potenti
influenc
report
delay
estim
rt
base
report
posit
case
daili
data
report
number
posit
neg
test
us
state
download
wwwcovidtrackingcom
april
covid
track
project
data
come
statedistrictterritori
public
health
author
occasion
trust
news
sourc
offici
press
confer
rare
social
media
updat
state
public
health
author
governor
data
sourc
document
spreadsheet
analyz
data
march
onward
first
date
neg
test
consist
report
entir
us
test
practic
vari
consider
state
state
chang
guidelin
week
outbreak
depend
test
avail
outbreak
intens
health
system
infrastructur
extract
inform
test
criteria
state
websit
week
march
week
april
data
sourc
document
si
dataset
exampl
march
louisiana
recommend
test
peopl
fever
respiratori
symptom
neg
influenza
test
prioriti
given
follow
categori
hospit
patient
sever
respiratori
ill
known
caus
suspect
outbreak
among
associ
individu
recent
onset
similar
fever
lower
respiratori
symptom
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
recent
fever
lower
respiratori
symptom
healthcar
worker
direct
contact
laboratoryconfirm
case
suspect
patient
associ
highrisk
exposur
set
longterm
care
facil
correct
facil
suspect
homeless
patient
howev
april
anyon
fever
respiratori
symptom
elig
test
regardless
influenza
statu
pharmacist
given
permiss
order
administ
test
durat
public
health
emerg
estim
data
number
report
posit
case
us
differ
state
fit
poisson
regress
model
first
three
week
data
march
march
estim
growth
rate
state
report
case
earli
poisson
regress
model
fit
data
begin
first
day
posit
case
report
march
approxim
one
week
nation
day
slow
spread
guidelin
announc
march
assum
mean
serial
interv
day
averag
latent
period
day
base
calcul
ci
estim
base
uncertainti
estim
growth
rate
account
uncertainti
serial
interv
latent
period
estim
timevari
reproduct
number
state
gener
use
wallingateuni
method
describ
assum
gener
interv
gamma
distribut
mean
day
coeffici
variat
estim
april
increasingli
uncertain
secondari
case
expect
occur
end
avail
data
base
cumul
distribut
function
gener
interv
later
date
present
uncorrect
estim
estim
correct
rightcensor
describ
europ
us
implic
even
modest
public
health
goal
requir
comprehens
intervent
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
fig
simul
epidem
differ
model
scenario
explor
chang
test
practic
number
incid
infect
true
case
grey
individu
test
red
confirm
case
posit
test
blue
predict
stochast
seir
model
popul
million
model
scenario
describ
tabl
true
case
test
observ
case
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
fig
estim
basic
reproduct
number
r
base
simul
data
estim
valu
base
growth
rate
number
true
case
black
number
confirm
case
blue
number
test
perform
red
plot
model
scenario
describ
tabl
mean
valu
repres
open
circl
vertic
line
repres
confid
interv
ci
base
uncertainti
growth
rate
grey
horizont
line
repres
mean
valu
true
across
scenario
ccbi
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
version
post
april
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
authorfund
grant
medrxiv
licens
display
preprint
perpetu
certifi
peer
review
copyright
holder
preprint
version
post
april
http
doi
medrxiv
preprint
